Heinrich Elinzano

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 356 citations · Full text

Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma

Jerrold L. Boxerman, Benjamin M. Ellingson, Suriya Jeyapalan et al. · American Journal of Clinical Oncology · 2014 · 92 citations

Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety

Tyler Y. Kang, Tony Jin, Heinrich Elinzano et al. · Journal of Neuro-Oncology · 2008 · 84 citations

Neuro-oncology, Medicine, Pharmacotherapy +7

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution

Ovidiu Marina, John H. Suh, C.A. Reddy et al. · Journal of neurosurgery · 2011 · 58 citations